ARCHIVES

Partnership Points to New Path Forward For Drug Approval and Clinical Research

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

May 9, 2014

Foundations: Lasker Awards honor Work In Nitric Oxide, HIB Vaccine

October 4, 1996

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

In Brief: James Cancer Hospial Recieves $20M Donation

January 22, 1999